What is the vasopressin equivalent dose for 5 µg desmopressin (DDAVP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Desmopressin to Vasopressin Dose Equivalence

5 mcg of desmopressin is equivalent to approximately 20 IU of vasopressin antidiuretic activity.

Direct Conversion Based on FDA Label

According to the FDA drug label, 1 mcg of desmopressin acetate is equivalent to 4 IU of antidiuretic activity 1. Using this conversion:

  • 5 mcg desmopressin = 20 IU vasopressin (antidiuretic units)

Important Clinical Context

Potency Differences

Desmopressin is a synthetic analogue of arginine vasopressin with fundamentally different pharmacologic properties 1:

  • Antidiuretic-to-pressor ratio: Desmopressin has a ratio of 4000:1, compared to 1:1 for natural arginine vasopressin 2
  • This means desmopressin provides potent antidiuretic effects with minimal vasopressor activity
  • The structural modification results in decreased vasopressor action and decreased visceral smooth muscle effects relative to enhanced antidiuretic activity 1

Pharmacokinetic Considerations

The biphasic half-lives differ significantly 1:

  • Desmopressin: 7.8 minutes (fast phase) and 75.5 minutes (slow phase)
  • Lysine vasopressin: 2.5 minutes (fast phase) and 14.5 minutes (slow phase)

This results in desmopressin providing prompt onset with longer duration of action compared to natural vasopressin.

Critical Caveat

These medications are NOT interchangeable in clinical practice. While the antidiuretic unit conversion exists (1 mcg = 4 IU), desmopressin and vasopressin have vastly different clinical applications, safety profiles, and hemodynamic effects. Desmopressin is used for diabetes insipidus and bleeding disorders, while vasopressin is primarily used for vasopressor support in shock states. The 20 IU equivalence refers only to antidiuretic potency, not to overall clinical effect or appropriate dosing for any given indication.

References

Research

DDAVP in the treatment of central diabetes insipidus.

The New England journal of medicine, 1976

Related Questions

What are the indications for intranasal desmopressin?
What are the indications, dosing, and monitoring guidelines for intravenous desmopressin?
How is desmopressin (DDAVP) indicated, dosed, and monitored for central diabetes insipidus, nocturnal enuresis, and mild hemophilia A or type 1 von Willebrand disease?
How do vasopressin (antidiuretic hormone, ADH) and desmopressin differ in their receptor-level actions?
How should desmopressin (DDAVP) be administered intravenously in an adult with central diabetes insipidus, including dosing, monitoring, and contraindications?
How should the laboratory results (glycated hemoglobin, complete blood count, comprehensive metabolic panel, and renal and hepatic function tests) be interpreted in a middle‑aged man with type 2 diabetes complicated by recent diabetic ketoacidosis, a testicular‑kidney infection, poor glycemic control, currently on basal insulin glargine and metformin (with empagliflozin and glipizide discontinued)?
What are the indications, dosing regimen, administration instructions, adverse effects, and contraindications for sucralfate?
Given my isolated anti‑RNP positivity with normal CBC, metabolic panel, liver enzymes, and urinalysis, am I currently experiencing active, life‑threatening autoimmune disease (i.e., 'cooked')?
What is the appropriate management for an eyelid cyst?
Can apixaban and carvedilol be co-administered in a patient with paroxysmal atrial fibrillation?
Can fluticasone propionate nasal spray (Flonase) be used concurrently with azelastine nasal spray in an adult with allergic rhinitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.